Genomics England Limited operates as a research-based biotechnology company focused on comprehensive genomic analysis, utilizing advanced technologies to understand human health complexities. Founded in April 2013 and currently active, Genomics specializes in the study of an individual’s entire genome – encompassing genetic information alongside environmental influences – through sophisticated sequencing techniques. The core service offered is the detailed examination of a person's complete genetic profile, identifying variations and patterns that contribute to disease risk or treatment response. This includes investigating complex interactions between genes and environment impacting health outcomes. Genomics provides bespoke research services for pharmaceutical companies, clinical diagnostic laboratories, and academic institutions globally. Their international presence extends through partnerships and collaborations across Europe and North America. The company’s size is estimated as a small-to-medium sized business, prioritizing skilled workforce development to ensure the highest quality of genomic analysis. They are categorized under SIC codes related to biotechnology research and experimental development specifically within the areas of genetics and genomics.

Genomics England Limited operates as a research-based biotechnology company focused on comprehensive genomic analysis, utilizing advanced technologies to understand human health complexities. Founded in April 2013 and currently active, Genomics specializes in the study of an individual’s entire genome – encompassing genetic information alongside environmental influences – through sophisticated sequencing techniques. The core service offered is the detailed examination of a person's complete genetic profile, identifying variations and patterns that contribute to disease risk or treatment response. This includes investigating complex interactions between genes and environment impacting health outcomes. Genomics provides bespoke research services for pharmaceutical companies, clinical diagnostic laboratories, and academic institutions globally. Their international presence extends through partnerships and collaborations across Europe and North America. The company’s size is estimated as a small-to-medium sized business, prioritizing skilled workforce development to ensure the highest quality of genomic analysis. They are categorized under SIC codes related to biotechnology research and experimental development specifically within the areas of genetics and genomics.